
Loading, please wait...

Loading, please wait...

The Supreme Court recently addressed the ongoing debate regarding a menstrual leave policy India. This discussion highlights the delicate balance between supporting women's health and maintaining workplace equity. However, the bench cautioned that making such leave mandatory might negatively impact female employment rates. Thus, the court urged the government to examine the potential fallout before making any policy decisions.
The bench expressed concerns that mandatory policies could lead to a psychological barrier in the job market. Consequently, employers might perceive female workers as less productive than their male counterparts. This perception could inadvertently discourage firms from hiring women. Furthermore, the court noted that the constitution recognises affirmative action for women. However, they warned that businesses might avoid giving significant responsibilities to women if leave is compulsory. On the judicial side, the bench noted a specific concern. They stated that day-to-day trials might be difficult to assign if mandatory leave periods are strictly enforced. Therefore, the court believes that voluntary implementation by companies is more appropriate than a judicial mandate.
Several countries already have established protocols for menstrual health. For instance, Spain provides government-funded period leave for three to five days. Similarly, Japan and South Korea enacted such laws several decades ago. Historically, the Soviet Union also provided paid absence for pain during menstruation. Within India, Bihar has maintained a functional policy since 1992. Additionally, Karnataka has implemented similar measures within its school system. However, the Supreme Court emphasizes that the government must frame these policies rather than the judiciary. They warned the petitioner against pursuing the issue for a third time without government intervention. Finally, the bench stressed that a model policy should balance health needs with the reality of the job market.
Q1: What did the Supreme Court say about mandatory leave?
The court warned that making leave compulsory could create a psychological barrier and deter firms from hiring women.
Q2: Which Indian states have already implemented menstrual leave policies?
Bihar has provided leave since 1992, and Karnataka has implemented it in schools.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Supreme Court warns that a mandatory menstrual leave policy India may deter hiring, suggesting the government should decide after studying potential fal...
4 months ago

A landmark study reveals that Milk Fat Globule-EGF Factor 8 (MFG-E8) protects hepatocytes from ferroptotic death and preserves epithelial integrity during liver injury, highlighting novel therapeutic targets for hepatic regeneration and acute liver failure management.
Today

A prospective study evaluates the fetal Evans Index in late-onset fetal growth restriction, uncovering anterior cerebral remodeling rather than ventriculomegaly, with conventional growth metrics retaining primary prognostic power for neonatal intensive care unit admission.
Today

Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today